Galectin Therapeutics Discusses Corporate Transformation, Progress of NAVIGATE Trial and Outlines Strategy for Potential Phase 2 Cancer Immunotherapy Trial at Annual Meeting

NEXT STORY
Akoya Biosciences Announces a Groundbreaking Collaboration with PathAI to Combine Spatial Biology with AI-Powered Tools to Facilitate Discovery of Novel Predictive Biomarkers
PREV STORY
Arch Therapeutics Granted Federal Supply Schedule and General Supply Administration Contracts for AC5® Advanced Wound System
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

eTrueNorth Launches National Voucher Solution Program Enabling Wellness Screenings at Retail Pharmacies

Local retail pharmacies accept eLabNetwork® vouchers and provide wellness screeningsFORT WORTH, Texas, Oct. 04, ...

author_avatar
NASDAQ Market News

Arbutus Announces New Data on AB-729 in Late Breaker Poster Presentation at AASLD – The Liver Meeting®

author_avatar
NASDAQ Market News

Over 20,000 Patients Treated with the Non-Surgical Zephyr Valve for Severe Emphysema, a Form of COPD

author_avatar
NASDAQ Market News